Professional Documents
Culture Documents
Features and Diagnosis Sifilis
Features and Diagnosis Sifilis
All topics are updated as new evidence becomes available and our peer review process is complete.
Literature review current through: May 2022. | This topic last updated: Mar 26, 2021.
INTRODUCTION
Congenital syphilis occurs when the spirochete Treponema pallidum is transmitted from a
pregnant woman to her fetus. Infection can result in stillbirth, prematurity, or a wide spectrum
of clinical manifestations; only severe cases are clinically apparent at birth [1].
The clinical features and diagnosis of congenital syphilis will be discussed here. The evaluation,
management, and prevention of congenital syphilis are discussed separately. (See "Congenital
syphilis: Evaluation, management, and prevention".)
CASE DEFINITION
https://www.uptodate.com/contents/14428/print 1/56
6/19/22, 10:55 PM 14428
The Centers for Disease Control and Prevention (CDC) case definition for congenital syphilis is
provided in the table ( table 1) [1]. Other case definitions may differ slightly from the CDC
definition [2]. In general, case definitions for congenital syphilis require only one of two criteria:
● The child was born to a mother with untreated, inadequately, or suboptimally treated
syphilis (presumed congenital syphilis) ( table 2)
Some experts would also presume infants to have congenital syphilis if their mothers had
contact with a person with primary or secondary syphilis within 90 days before delivery and
were not treated or were inadequately treated [3,4].
EPIDEMIOLOGY
Congenital syphilis is a significant public health problem, complicating an estimated one million
pregnancies per year throughout the world [5]. The incidence of congenital syphilis reflects the
rate of syphilis in women of childbearing age [6]. (See "Syphilis: Epidemiology, pathophysiology,
and clinical manifestations in patients without HIV", section on 'Epidemiology'.)
Most cases develop because the mother received no prenatal care or insufficient treatment for
syphilis before or during pregnancy ( table 2) [7-10]. Among women with untreated early
syphilis, 40 percent of pregnancies result in spontaneous abortion [11]. (See "Syphilis in
pregnancy", section on 'Prevalence'.)
In the United States, the rate of congenital syphilis among infants <1 year of age peaked at
approximately 100 cases per 100,000 live births in 1991 (in part because of a change in the case
definition to include infants born to women with untreated or inadequately treated syphilis in
1988), then declined steadily in the 1990s and early 2000s [8]. Since 2012, there has been a
steady year-on-year increase in reported cases [12,13]. In 2018, there were a total of 1306
reported cases of congenital syphilis in the United States, including 78 syphilitic stillbirths and
16 infant deaths [13,14]. This represents the highest reported rate since 1991. The 2018 case
rate (33 cases per 100,000 live births) represents a 40 percent increase relative to 2017 and a
nearly 400 percent increase relative to 2012. As is expected, the increase in rates of congenital
syphilis parallels increases in primary and secondary syphilis among all women and
reproductive-aged women during this period ( figure 1) [12-15].
https://www.uptodate.com/contents/14428/print 2/56
6/19/22, 10:55 PM 14428
Poor access to prenatal care is an important risk factor for congenital syphilis. Among the 458
cases of congenital syphilis reported to the Centers for Disease Control and Prevention in 2014,
nearly one-quarter were born to mothers who did not receive prenatal care [12]. Among the
314 cases in which the mother received prenatal care, 135 (43 percent) received no treatment
for syphilis during the pregnancy and 94 (30 percent) received inadequate treatment. Similarly,
in a report by the New York City Department of Health and Mental Hygiene of 578 syphilis
infections reported in pregnant women during 2010 to 2016, >85 percent did not result in
congenital infection, presumably because of early screening and treatment [16]. Of the 68 cases
of congenital syphilis that occurred, 31 percent were born to women who received no prenatal
care or did not have a syphilis test ≥45 days before delivery. In addition, of the women who had
appropriate testing during pregnancy, 15 percent received no or inadequate treatment.
Obstacles to accessing health care identified in this report included substance use, mental
health disorders, recent arrival in the United States, unstable housing, and lack of health care
coverage.
The rate of congenital syphilis is increased among infants born to mothers with HIV infection.
However, the contribution of maternal coinfection with syphilis and HIV to vertical transmission
of either syphilis or HIV is not completely understood. (See "Syphilis in patients with HIV",
section on 'Effect of syphilis on HIV'.)
The rate of congenital syphilis is generally low among children adopted internationally; however
it is relatively increased among those adopted from Africa ( table 3). Given the difficulty in
confirming adequate treatment/treatment response of the birth mother and the risk of long-
term sequelae in untreated children, we recommend screening international adoptees for
congenital syphilis (regardless of the country of origin). (See "International adoption: Infectious
disease aspects", section on 'Syphilis'.)
TRANSMISSION
Humans are the only natural host of T. pallidum [17]. Congenital syphilis generally is acquired
through transplacental transmission of spirochetes in the maternal bloodstream or,
occasionally, through direct contact with an infectious lesion during birth [18-20]. (See "Syphilis
in pregnancy", section on 'Vertical transmission'.)
Transplacental transmission of T. pallidum can occur at any time during gestation but occurs
with increasing frequency as gestation advances. Women with untreated primary or secondary
syphilis are more likely to transmit syphilis to their fetuses than women with latent disease (60
to 90 versus 40 percent in early latent and <10 percent in late latent syphilis) [21,22]. The risk of
https://www.uptodate.com/contents/14428/print 3/56
6/19/22, 10:55 PM 14428
transmission decreases with increasing time since primary or secondary infection and is only 2
percent after four years.
T. pallidum is not transferred in breast milk, but transmission may occur if the mother has an
infectious lesion (eg, chancre) on her breast [23].
PATHOGENESIS
At the onset of congenital syphilis, T. pallidum is liberated directly into the circulation of the
fetus, resulting in spirochetemia with widespread dissemination to almost all organs. The
clinical manifestations result from the inflammatory response. The bones, liver, pancreas,
intestine, kidney, and spleen are the most frequently and severely involved. The severity of the
manifestations is variable and can range from isolated laboratory or radiographic abnormalities
to fulminant involvement of multiple organ systems. Overt infection can manifest in the fetus,
the newborn, or later in childhood (if the infant is not treated) [24].
The pathophysiology of and immune response to acquired syphilis infection are discussed
separately. (See "Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients
without HIV".)
Clinical findings — Early congenital syphilis is arbitrarily defined by clinical manifestations with
onset before two years of age [4]. Clinical manifestations in untreated infants usually appear by
three months of age, most often by five weeks [4,25].
● Hepatomegaly
● Jaundice
● Nasal discharge ("snuffles")
● Rash
● Generalized lymphadenopathy
● Skeletal abnormalities
https://www.uptodate.com/contents/14428/print 4/56
6/19/22, 10:55 PM 14428
● Placenta and umbilical cord – The placenta of neonates with congenital syphilis is often
large, thick, and pale. The umbilical cord is edematous and may resemble a "barber's pole"
with spiral stripes of red and light blue discoloration alternating with streaks of chalky
white. It may be significantly inflamed with an abscess-like foci of necrosis within Wharton
jelly, centered around the umbilical vessels (necrotizing funisitis) [30,31]. (See "Care of the
umbilicus and management of umbilical disorders", section on 'Funisitis'.)
● Rhinitis – Syphilitic rhinitis ("snuffles") ( picture 1) may herald the onset of congenital
syphilis. It usually develops during the first week of life and seldom after the third month.
The nasal discharge is white and may be bloody (secondary to mucosal erosion) or
purulent if there is secondary bacterial infection. It is more severe and persistent than the
nasal discharge of the common cold (see "The common cold in children: Clinical features
and diagnosis", section on 'Clinical features'). The nasal discharge contains spirochetes, is
contagious, and can transmit infection by direct contact. It should be examined by
darkfield microscopy to confirm the diagnosis. (See 'Younger than one month' below.)
● Rash – The rash of congenital syphilis usually appears one to two weeks after the rhinitis.
It is maculopapular and consists of small, initially red or pink spots. The lesions may occur
anywhere, but are more prominent on the back, buttocks, posterior thighs, and soles (
picture 2). The rash generally progresses over one to three weeks, followed by
desquamation and crusting. As it fades, the lesions become dusky red or copper-colored,
and the pigmentation may persist. If present at birth, the rash may be widely
disseminated and bullous (pemphigus syphiliticus). Ulcerative lesions and bullous fluid
contain spirochetes, are contagious, and can transmit infection by direct contact; samples
https://www.uptodate.com/contents/14428/print 5/56
6/19/22, 10:55 PM 14428
of such lesions should be examined by darkfield microscopy to confirm the diagnosis. (See
'Younger than one month' below.)
Central nervous system syphilis — Central nervous system (CNS) syphilis in children with
congenital infection may be asymptomatic or symptomatic. Asymptomatic CNS syphilis is
indicated by abnormalities in the cerebrospinal fluid (see 'Cerebrospinal fluid abnormalities'
below). Asymptomatic CNS syphilis occurs in approximately 40 percent of infants who have
clinical, laboratory, or radiographic abnormalities of congenital syphilis, but is infrequent in
infants without such manifestations [17,38-42].
Symptomatic CNS involvement is rare among infants with congenital syphilis in the era of
penicillin therapy but may develop from ongoing dissemination in infants who are not treated
https://www.uptodate.com/contents/14428/print 6/56
6/19/22, 10:55 PM 14428
in the neonatal period [17]. Symptomatic CNS syphilis in infants has two overlapping
presentations: acute syphilitic leptomeningitis and chronic meningovascular syphilis.
● Acute syphilitic leptomeningitis typically manifests during the first year of life, usually
between three and six months. The clinical findings are suggestive of bacterial meningitis
(eg, vomiting, bulging fontanelle, increased head circumference, splitting of the cranial
sutures), but the CSF findings are more suggestive of aseptic meningitis (predominance of
mononuclear cells, modest increase in protein, normal glucose) [17,23]. Acute syphilitic
leptomeningitis generally responds to penicillin therapy.
● Chronic meningovascular syphilis typically manifests toward the end of the first year [17].
The clinical findings include signs of progressive hydrocephalus, cranial nerve palsies,
papilledema, optic atrophy, neurodevelopmental regression, and seizures. Syphilitic
endarteritis may cause cerebral infarction in the second year of life.
In addition, pituitary gland involvement may manifest with persistent hypoglycemia or diabetes
insipidus [43,44].
Radiographic abnormalities
The radiographic abnormalities characteristically are bilateral, symmetric, and polyostotic; the
femur, humerus, and tibia are most frequently involved. Findings may include [47-49]:
● Metaphyseal lucent bands (this finding may occur in response to other systemic illnesses) (
image 1).
● Symmetric localized demineralization and osseous destruction of the medial portion of the
proximal tibial metaphysis (Wimberger sign), which also may occur in neonatal
hyperparathyroidism and osteomyelitis.
● Diaphyseal periostitis with new bone formation (may occur in other conditions) (
image 2).
https://www.uptodate.com/contents/14428/print 7/56
6/19/22, 10:55 PM 14428
Long-bone abnormalities may be helpful in the diagnosis of congenital syphilis and may be
warranted in [50-52]:
● Neonates who have Venereal Disease Research Laboratory (VDRL) or rapid plasma reagin
(RPR) titers less than fourfold the maternal titer, normal physical examination, and whose
mothers were not treated or were inadequately treated ( table 2); were treated ≤4 weeks
before delivery; or have evidence of relapse or reinfection (fourfold or greater increase in
titers). (See "Congenital syphilis: Evaluation, management, and prevention", section on
'Possible congenital syphilis'.)
● Infants and children with reactive VDRL or RPR and with abnormal skeletal findings on
physical examination (eg, extremity pain, lack of movement of one or more extremities).
(See "Congenital syphilis: Evaluation, management, and prevention", section on 'Proven or
highly probable disease' and "Congenital syphilis: Evaluation, management, and
prevention", section on 'Evaluation and management of children >1 month of age'.)
Chest radiographs — Complete opacification of both lung fields ("pneumonia alba") is the
classic radiographic appearance of pneumonia in infants with congenital syphilis. However, a
fluffy, diffuse infiltrate involving all lung areas is more common in the era of penicillin therapy.
Laboratory abnormalities
● Anemia – Direct Coomb test (also known as direct antiglobulin test) negative hemolytic
anemia in the neonatal period; nonhemolytic anemia after the neonatal period
● Thrombocytopenia
● Leukopenia or leukocytosis
https://www.uptodate.com/contents/14428/print 8/56
6/19/22, 10:55 PM 14428
● CSF pleocytosis (defined by consensus as >25 white blood cells [WBC]/microL for infants <1
month, although some experts use a threshold of >5 WBC/microL).
● Elevated CSF protein (defined by consensus as >150 mg/dL in term infants <1 month of
age and >170 mg/dL in preterm infants <1 month of age, although some experts use a
threshold of >40 mg).
However, none of these findings is highly sensitive or specific [40,42]. In an observational study
that used the rabbit infectivity test as the reference standard for identification of spirochetes in
the CSF, the sensitivity and specificity of reactive CSF VDRL, elevated CSF WBC, and elevated CSF
protein were as follows [40]:
The significance of a reactive CSF VDRL in a neonate is not clear, since there may be false
positives (related to maternal nontreponemal immunoglobulin G [IgG] antibodies that cross the
placenta and diffuse into the fetal CSF or contamination of the CSF with blood from a traumatic
lumbar puncture) and false negatives (neonates with initial nonreactive CSF VDRL may
subsequently develop signs of neurosyphilis). (See 'Congenital neurosyphilis' below.)
Examination of the CSF for T. pallidum DNA by polymerase chain reaction (PCR) may prove more
useful for definitive diagnosis of congenital neurosyphilis [18,40,41], but this test is not widely
available. (See 'Diagnostic tests' below.)
Late congenital syphilis is arbitrarily defined by clinical manifestations with onset after two
years of age [4]. Manifestations of late congenital syphilis are related to scarring or persistent
inflammation from early infection and are characterized by gumma formation in various tissues
[55]. Late congenital syphilis develops in approximately 40 percent of infants born to women
with untreated syphilis during pregnancy. Some manifestations of late congenital syphilis can
be prevented by treatment of the mother during pregnancy or treatment of the infant within
the first three months of life [56,57]. However, other manifestations (eg, keratitis, saber shins)
may occur or progress despite appropriate therapy [58].
https://www.uptodate.com/contents/14428/print 9/56
6/19/22, 10:55 PM 14428
● Facial features – Frontal bossing ( picture 3), saddle nose, short maxilla, protuberant
mandible.
● Eyes – Interstitial keratitis ( picture 4) (bilateral, usually occurs around puberty but can
occur anytime between 4 and 30 years), secondary glaucoma, corneal scarring, optic
atrophy.
● Ears – Sensorineural hearing loss associated with late congenital syphilis typically develops
suddenly at 8 to 10 years of age and often accompanies interstitial keratitis. The higher
frequencies are affected first; normal conversational tones are affected later. Syphilis-
associated hearing loss may respond to long-term glucocorticoid therapy [61].
● Cutaneous – Rhagades (perioral fissures or a cluster of scars radiating around the mouth) (
picture 8), gummas (granulomatous inflammatory response to spirochetes) in the skin
or mucous membranes.
● Skeletal – Anterior bowing of the shins ("saber shins") ( picture 9), enlargement of the
sternoclavicular portion of the clavicle (Higoumenakis sign), painless arthritis of the knees
("Clutton joints") ( picture 10), and, rarely, other joints.
Among these manifestations, Hutchinson triad (Hutchinson teeth, interstitial keratitis, and
sensorineural hearing loss), mulberry molars, and Clutton joints are relatively specific for
congenital syphilis [23,59].
DIFFERENTIAL DIAGNOSIS
The manifestations of congenital syphilis in neonates may be similar to those of other neonatal
infections or newborn conditions, including:
https://www.uptodate.com/contents/14428/print 10/56
6/19/22, 10:55 PM 14428
● Herpes simplex virus infection (see "Neonatal herpes simplex virus infection: Clinical
features and diagnosis", section on 'Evaluation and diagnosis')
● Neonatal sepsis (see "Clinical features, evaluation, and diagnosis of sepsis in term and late
preterm infants", section on 'Evaluation and initial management')
● Hydrops fetalis (see "Nonimmune hydrops fetalis", section on 'Etiology and prenatal
management of disorders associated with hydrops' and "Postnatal diagnosis and
management of hemolytic disease of the fetus and newborn", section on 'Diagnosis')
● Vesicular lesions (see "Vesicular, pustular, and bullous lesions in the newborn and infant")
Historical features, additional findings, and/or laboratory testing usually differentiate these
conditions from congenital syphilis.
DIAGNOSTIC TESTS
https://www.uptodate.com/contents/14428/print 11/56
6/19/22, 10:55 PM 14428
Tests that may be used to establish the diagnosis of congenital syphilis in research settings
include:
● Detection of T. pallidum DNA in a clinical specimen (eg, polymerase chain reaction [PCR])
[18,40,41,64]
These testing methods are discussed in detail separately. (See "Syphilis: Screening and
diagnostic testing", section on 'Diagnostic tests'.)
Darkfield microscopy can be performed on body fluids (eg, nasal discharge) or moist skin
lesions [65]. Darkfield microscopy enables demonstration of thin, delicate, corkscrew-shaped
organisms with rigid, tightly wound spirals ( picture 11). A positive darkfield slide illustrates
the characteristic motility associated with T. pallidum: a forward and backward motion with
rotation about the longitudinal axis [65]. Soft side-to-side bending and twisting may also be
seen. Failure to identify spirochetes with darkfield microscopy does not exclude the diagnosis of
syphilis. Darkfield microscopy depends upon the direct visualization of live, active spirochetes,
characteristics that are rapidly destroyed by the previous use of antibiotics.
Nontreponemal tests are inexpensive and rapidly performed. They are sensitive, but not
specific. Nontreponemal tests generally are used in the evaluation of neonates with possible
congenital syphilis because they provide quantitative results, which can be compared with
simultaneously obtained maternal results to categorize neonatal infection [52]. The neonate's
nontreponemal titer usually is one to two dilutions less than that of the mother [66]. When the
mother's titer is low, the neonate may have nonreactive serology but remains at risk for
congenital syphilis. (See 'Congenital syphilis less likely' below.)
Serologic tests for immunoglobulin G [IgG] antibodies are problematic because it is not possible
to differentiate between passively acquired maternal antibody and endogenous antibody
produced by the fetus/neonate. The ability to detect immunoglobulin M [IgM] antibodies, which
https://www.uptodate.com/contents/14428/print 12/56
6/19/22, 10:55 PM 14428
do not cross the placenta, would confirm fetal infection. Unfortunately, a sufficiently sensitive
and specific IgM assay is not available for routine use in the assessment of congenital syphilis
[51]. The fluorescent anti-treponemal IgM antibody test IgM FTA-ABS was used in the past, but
because of lack of sensitivity [67,68], the Centers for Disease Control and Prevention suspended
its use for diagnostic testing of infants.
The rabbit infectivity test (RIT), which involves the inoculation of cerebrospinal fluid [CSF] or
other body fluids into rabbits to determine the presence of viable T. pallidum, is the reference
standard test for congenital syphilis [23,25,55]. However, routine use of RIT is not practical
because it involves animal testing and is not widely available.
PCR has been used on neonatal blood and CSF for diagnosis of congenital syphilis, but these
tests are not widely available [18,40,41,69]. Compared with isolation of the spirochetes by rabbit
infectivity testing, the sensitivity and specificity of PCR on cerebrospinal fluid was 65 to 71
percent and 97 to 100 percent, respectively [40,41]. Among 17 infants who had spirochetes
detected in CSF by rabbit inoculation, blood PCR was the best predictor of central nervous
system infection with T. pallidum [40].
APPROACH TO DIAGNOSIS
The vagaries of the maternal history and signs or lack of signs in the newborn in combination
with the potential consequences of delayed or missed diagnosis of congenital syphilis demand
a "safety first" approach to both diagnosis and treatment [4]. The Centers for Disease Control
and Prevention (CDC) and the American Academy of Pediatrics (AAP) Committee on Infectious
Diseases provide guidelines for the evaluation and management of congenital syphilis (
algorithm 1 and table 6) [51,52]. Maternal nontreponemal test results are required for
entry into the algorithm.
The CDC and AAP guidelines recommend that maternal samples be screened according to the
traditional algorithm (ie, a nontreponemal test followed by a treponemal test if the
nontreponemal test is positive). However, some laboratories screen samples in reverse (ie, a
treponemal test before the nontreponemal test) [70]. Interpretation of results with reverse
sequence screening is discussed separately. (See "Syphilis: Screening and diagnostic testing",
section on 'Serologic testing algorithms'.)
Point-of-care testing (usually linked with HIV testing) using immunochromatographic strips
provides an alternative to laboratory testing that is particularly useful in resource-limited
settings. These tests can be done during antenatal visits, do not require the laboratory
https://www.uptodate.com/contents/14428/print 13/56
6/19/22, 10:55 PM 14428
infrastructure necessary for conventional tests, and can be performed on finger-stick blood
samples. They are easy to perform, it is easy to interpret their results, and they have a quick
turnaround time of 20 minutes or so. They have good sensitivity and specificity, comparable to
those of conventional treponemal and nontreponemal tests [70,71].
Clinical suspicion — The diagnosis of congenital syphilis should be suspected in all infants
born to women who have reactive nontreponemal and treponemal tests for syphilis; the
treponemal test is necessary to exclude a false-positive nontreponemal test (see "Syphilis in
pregnancy"). The diagnosis of congenital syphilis also should be suspected in infants born to
women who are identified clinically or through contact tracing as having early syphilis during
the three months after delivery [4].
In addition, the possibility of congenital syphilis should be considered in infants and children
with the following nonspecific clinical findings, particularly in infants born to women with a
history of syphilis or risk factors for syphilis (see "Syphilis in pregnancy", section on
'Prevalence'):
Finally, the possibility of congenital syphilis should be suspected in children who are adopted
internationally. (See "International adoption: Infectious disease aspects", section on 'Syphilis'.)
Initial evaluation
Younger than one month — The initial evaluation of infants younger than one month of age
who were born to women with reactive nontreponemal and treponemal test results should
include ( algorithm 1 and table 6) [51,52]:
https://www.uptodate.com/contents/14428/print 14/56
6/19/22, 10:55 PM 14428
Additional evaluation depends upon the findings from the initial evaluation and is discussed
separately. (See "Congenital syphilis: Evaluation, management, and prevention", section on
'Subsequent evaluation and management'.)
Older than one month — The initial evaluation of infants and children older than one month
of age with clinical, radiographic, or laboratory manifestations compatible with congenital
syphilis should include a quantitative VDRL or RPR, physical examination, and darkfield
microscopic examination (if it is available) or direct fluorescent antibody staining of suspicious
body fluids [51,52].
Infants and children who are found to have reactive serologic tests for syphilis when they are
older than one month of age should have maternal serology and records reviewed to assess
whether the child has congenital or acquired syphilis, although this distinction may be difficult
[1,24]. Additional evaluation of such children may include [51,52]:
● Cerebrospinal fluid (CSF) analysis for VDRL, cell count, and protein
● Complete blood count with differential and platelet count
● Evaluation and testing for HIV infection
● Other tests as clinically indicated (eg, chest radiograph, long-bone radiographs, liver
function tests, abdominal ultrasonography, ophthalmologic examination, and auditory
brainstem response, and neuroimaging studies)
CSF and complete blood count abnormalities may occur in both congenital and acquired
syphilis, but radiographic abnormalities are more suggestive of congenital than acquired
syphilis. (See 'Radiographic abnormalities' above.)
https://www.uptodate.com/contents/14428/print 15/56
6/19/22, 10:55 PM 14428
● A positive darkfield ( picture 11) or fluorescent antibody test of lesions, body fluid(s),
placenta, or umbilical cord (these procedures may not be available in all centers)
Neonates with proven or highly probable congenital syphilis should undergo further evaluation
and treatment. (See "Congenital syphilis: Evaluation, management, and prevention", section on
'Subsequent evaluation and management'.)
Possible congenital syphilis — Neonates with normal physical examination and serum VDRL
or RPR titers less than fourfold the maternal titer, but whose mothers were not treated or
received inadequate/suboptimal therapy ( table 2) are considered to have possible congenital
syphilis [51,52].
Some experts would also consider infants to have possible congenital syphilis if their mothers
had contact with a person with primary or secondary syphilis within 90 days before delivery and
were not treated or were inadequately treated, even if the mother had nonreactive serology
[3,4].
Additional evaluation and management of infants with possible congenital syphilis are
discussed separately. (See "Congenital syphilis: Evaluation, management, and prevention",
section on 'Possible congenital syphilis'.)
Congenital syphilis less likely — Infection is less likely if a neonate has a normal physical
examination, serum VDRL or RPR titers are <fourfold the maternal titer, mother received
appropriate treatment >4 weeks before delivery, and mother has no evidence of reinfection or
relapse. However, these neonates are at risk and should receive treatment with a single dose of
intramuscular penicillin G benzathine [51,52,73]. No additional evaluation is needed [51].
https://www.uptodate.com/contents/14428/print 16/56
6/19/22, 10:55 PM 14428
Management of infants in whom congenital syphilis is less likely is discussed separately. (See
"Congenital syphilis: Evaluation, management, and prevention", section on 'Congenital syphilis
less likely'.)
Congenital syphilis unlikely — A diagnosis of congenital syphilis is unlikely if the neonate has
a normal physical examination, serum VDRL or RPR titers are <fourfold the maternal titer,
mother was adequately treated before pregnancy, and mother's titers remained low (VDRL <1:2;
RPR <1:4) and stable before and during pregnancy and at delivery [51]. These infants generally
do not require any additional evaluation or treatment. (See "Congenital syphilis: Evaluation,
management, and prevention", section on 'Congenital syphilis unlikely'.)
The diagnosis of congenital neurosyphilis can be difficult to establish. Given the lack of a widely
available laboratory test with high sensitivity and specificity for CNS syphilis and the potential
consequences of untreated CNS syphilis, the diagnosis of CNS syphilis usually is presumed in
children with clinical, radiographic, and laboratory abnormalities compatible with congenital
syphilis. Children with presumed congenital neurosyphilis should be treated with 10 days of
parenteral penicillin [40]. (See 'Central nervous system syphilis' above and "Congenital syphilis:
Evaluation, management, and prevention", section on 'Penicillin therapy'.)
Congenital versus acquired syphilis — In children who are found to have reactive serologic
tests for syphilis when they are older than one month of age, the distinction between
congenital and acquired syphilis can be difficult [1]. The ultimate diagnosis may rest upon
maternal history and clinical judgment [1]. Radiographic abnormalities of the long bones are
more suggestive of congenital than acquired syphilis. (See 'Radiographic abnormalities' above.)
The possibility of sexual abuse must be considered in children who are determined to have
acquired syphilis. (See "Evaluation of sexual abuse in children and adolescents", section on
'Sexually transmitted infections'.)
REPORTING REQUIREMENTS
https://www.uptodate.com/contents/14428/print 17/56
6/19/22, 10:55 PM 14428
In the United States, congenital syphilis is a national notifiable disease [74]. However, reporting
requirements vary by state. Reporting to the Centers for Disease Control and Prevention by the
states is voluntary. For reporting purposes, congenital syphilis includes stillbirths due to
syphilis, cases of congenital syphilis detected in newborns, and cases of congenitally acquired
syphilis in infants and children [1].
UpToDate offers two types of patient education materials, "The Basics" and "Beyond the
Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade
reading level, and they answer the four or five key questions a patient might have about a given
condition. These articles are best for patients who want a general overview and who prefer
short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more
sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading
level and are best for patients who want in-depth information and are comfortable with some
medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to print
or email these topics to your patients. (You can also locate patient education articles on a
variety of subjects by searching on "patient education" and the keyword[s] of interest.)
● Early congenital syphilis is arbitrarily defined by clinical manifestations with onset before
two years of age. Manifestations of early clinical syphilis are varied and unpredictable (
table 4). (See 'Early congenital syphilis' above.)
● Late congenital syphilis is arbitrarily defined by clinical manifestations with onset after two
years of age. Manifestations of late congenital syphilis are related to scarring or persistent
inflammation from early infection ( table 5). (See 'Late congenital syphilis' above.)
https://www.uptodate.com/contents/14428/print 18/56
6/19/22, 10:55 PM 14428
● The Centers for Disease Control and Prevention (CDC) and the American Academy of
Pediatrics (AAP) Committee on Infectious Diseases provide guidelines for the evaluation
and management of congenital syphilis ( algorithm 1 and table 6). (See 'Approach to
diagnosis' above.)
● The diagnosis of congenital syphilis should be suspected in all infants born to women who
have reactive nontreponemal and treponemal tests for syphilis and infants/children with
clinical findings compatible with congenital syphilis ( table 4 and table 5). (See
'Clinical suspicion' above.)
● The initial evaluation for congenital syphilis in infants and children should include a
quantitative Venereal Disease Research Laboratory (VDRL) or rapid plasma reagin (RPR)
titer (for infants <1 month of age, the test should be the same as that which was
performed on the mother); physical examination for evidence of congenital syphilis;
darkfield microscopic examination or direct fluorescent antibody staining of suspicious
lesions or body fluids (eg, nasal discharge); and, for newborns, pathologic examination of
the placenta and umbilical cord with specific fluorescent antitreponemal antibody staining
(if possible). (See 'Initial evaluation' above.)
REFERENCES
1. Centers for Disease Control and Prevention. Syphilis (Treponema pallidum) 2018 Case Defin
ition. https://ndc.services.cdc.gov/case-definitions/syphilis-2018/ (Accessed on June 17, 202
1).
https://www.uptodate.com/contents/14428/print 19/56
6/19/22, 10:55 PM 14428
2. Risser WL, Hwang LY. Problems in the current case definitions of congenital syphilis. J
Pediatr 1996; 129:499.
3. Zenker PN, Berman SM. Congenital syphilis: trends and recommendations for evaluation
and management. Pediatr Infect Dis J 1991; 10:516.
4. Dobson SR, Sanchez PJ. Syphilis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Dis
eases, 8th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia
2019. p.1268.
5. Walker DG, Walker GJ. Prevention of congenital syphilis--time for action. Bull World Health
Organ 2004; 82:401.
6. Sexually transmitted disease surveillance, 2015. Centers for Disease Control and Preventio
n. Available at: https://www.cdc.gov/std/stats15/std-surveillance-2015-print.pdf (Accessed o
n October 25, 2016).
7. Reyes MP, Hunt N, Ostrea EM Jr, George D. Maternal/congenital syphilis in a large tertiary-
care urban hospital. Clin Infect Dis 1993; 17:1041.
8. Centers for Disease Control and Prevention (CDC). Congenital syphilis - United States, 2003-
2008. MMWR Morb Mortal Wkly Rep 2010; 59:413.
9. Caddy SC, Lee BE, Sutherland K, et al. Pregnancy and neonatal outcomes of women with
reactive syphilis serology in Alberta, 2002 to 2006. J Obstet Gynaecol Can 2011; 33:453.
10. Lago EG, Vaccari A, Fiori RM. Clinical features and follow-up of congenital syphilis. Sex
Transm Dis 2013; 40:85.
11. Centers for Disease Control and Prevention (CDC). Congenital syphilis--United States, 1998.
MMWR Morb Mortal Wkly Rep 1999; 48:757.
12. Bowen V, Su J, Torrone E, et al. Increase in incidence of congenital syphilis - United States,
2012-2014. MMWR Morb Mortal Wkly Rep 2015; 64:1241.
13. Kimball A, Torrone E, Miele K, et al. Missed Opportunities for Prevention of Congenital
Syphilis - United States, 2018. MMWR Morb Mortal Wkly Rep 2020; 69:661.
14. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 201
8: Syphilis. Available at: https://www.cdc.gov/std/stats18/syphilis.htm (Accessed on March 2
5, 2021).
15. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 201
7: National profile-Overview: Syphilis. Available at: https://www.cdc.gov/std/stats17/syphili
s.htm (Accessed on January 28, 2019).
16. Slutsker JS, Hennessy RR, Schillinger JA. Factors Contributing to Congenital Syphilis Cases
— New York City, 2010–2016. MMWR Morb Mortal Wkly Rep 2018; :1088.
https://www.uptodate.com/contents/14428/print 20/56
6/19/22, 10:55 PM 14428
17. Woods CR. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis 2005;
16:245.
18. Grimprel E, Sanchez PJ, Wendel GD, et al. Use of polymerase chain reaction and rabbit
infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera,
and cerebrospinal fluid. J Clin Microbiol 1991; 29:1711.
19. Nathan L, Twickler DM, Peters MT, et al. Fetal syphilis: correlation of sonographic findings
and rabbit infectivity testing of amniotic fluid. J Ultrasound Med 1993; 12:97.
20. Qureshi F, Jacques SM, Reyes MP. Placental histopathology in syphilis. Hum Pathol 1993;
24:779.
21. FIUMARA NJ, FLEMING WL, DOWNING JG, GOOD FL. The incidence of prenatal syphilis at
the Boston City Hospital. N Engl J Med 1952; 247:48.
22. INGRAHAM NR Jr. The value of penicillin alone in the prevention and treatment of
congenital syphilis. Acta Derm Venereol Suppl (Stockh) 1950; 31:60.
23. Kollmann TR, Dobson S. Syphilis. In: Infectious Diseases of the Fetus and Newborn Infant, 7
th, Remington JS, Klein JO, Wilson CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.52
4.
24. Christian CW, Lavelle J, Bell LM. Preschoolers with syphilis. Pediatrics 1999; 103:E4.
25. Herremans T, Kortbeek L, Notermans DW. A review of diagnostic tests for congenital
syphilis in newborns. Eur J Clin Microbiol Infect Dis 2010; 29:495.
26. Ortiz-Lopez N, Diez M, Diaz O, et al. Epidemiological surveillance of congenital syphilis in
Spain, 2000-2010. Pediatr Infect Dis J 2012; 31:988.
27. Rawstron SA, Hawkes SJ. Treponema pallidum (Syphilis). In: Principles and Practice of Pedia
tric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, Edin
burgh 2012. p.941.
28. Rathbun KC. Congenital syphilis. Sex Transm Dis 1983; 10:93.
29. Ricci JM, Fojaco RM, O'Sullivan MJ. Congenital syphilis: the University of Miami/Jackson
Memorial Medical Center experience, 1986-1988. Obstet Gynecol 1989; 74:687.
30. Fojaco RM, Hensley GT, Moskowitz L. Congenital syphilis and necrotizing funisitis. JAMA
1989; 261:1788.
31. Sheffield JS, Sánchez PJ, Wendel GD Jr, et al. Placental histopathology of congenital syphilis.
Obstet Gynecol 2002; 100:126.
32. Hollier LM, Harstad TW, Sanchez PJ, et al. Fetal syphilis: clinical and laboratory
characteristics. Obstet Gynecol 2001; 97:947.
https://www.uptodate.com/contents/14428/print 21/56
6/19/22, 10:55 PM 14428
33. Shah MC, Barton LL. Congenital syphilitic hepatitis. Pediatr Infect Dis J 1989; 8:891.
34. Braunstein GD, Lewis EJ, Galvanek EG, et al. The nephrotic syndrome associated with
secondary syphilis. An immune deposit disease. Am J Med 1970; 48:643.
35. Gamble CN, Reardan JB. Immunopathogenesis of syphilitic glomerulonephritis. Elution of
antitreponemal antibody from glomerular immune-complex deposits. N Engl J Med 1975;
292:449.
36. Kaplan BS, Wiglesworth FW, Marks MI, Drummond KN. The glomerulopathy of congenital
syphilis--an immune deposit disease. J Pediatr 1972; 81:1154.
37. Dobson SR, Taber LH, Baughn RE. Characterization of the components in circulating
immune complexes from infants with congenital syphilis. J Infect Dis 1988; 158:940.
38. Radcliffe M, Meyer M, Roditi D, Malan A. Single-dose benzathine penicillin in infants at risk
of congenital syphilis--results of a randomised study. S Afr Med J 1997; 87:62.
39. Paryani SG, Vaughn AJ, Crosby M, Lawrence S. Treatment of asymptomatic congenital
syphilis: benzathine versus procaine penicillin G therapy. J Pediatr 1994; 125:471.
40. Michelow IC, Wendel GD Jr, Norgard MV, et al. Central nervous system infection in
congenital syphilis. N Engl J Med 2002; 346:1792.
41. Sánchez PJ, Wendel GD Jr, Grimprel E, et al. Evaluation of molecular methodologies and
rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central
nervous system invasion by Treponema pallidum. J Infect Dis 1993; 167:148.
42. Beeram MR, Chopde N, Dawood Y, et al. Lumbar puncture in the evaluation of possible
asymptomatic congenital syphilis in neonates. J Pediatr 1996; 128:125.
43. Daaboul JJ, Kartchner W, Jones KL. Neonatal hypoglycemia caused by hypopituitarism in
infants with congenital syphilis. J Pediatr 1993; 123:983.
44. Nolt D, Saad R, Kouatli A, et al. Survival with hypopituitarism from congenital syphilis.
Pediatrics 2002; 109:e63.
45. Moyer VA, Schneider V, Yetman R, et al. Contribution of long-bone radiographs to the
management of congenital syphilis in the newborn infant. Arch Pediatr Adolesc Med 1998;
152:353.
46. Brion LP, Manuli M, Rai B, et al. Long-bone radiographic abnormalities as a sign of active
congenital syphilis in asymptomatic newborns. Pediatrics 1991; 88:1037.
47. Kocher MS, Caniza M. Parrot pseudoparalysis of the upper extremities. A case report. J
Bone Joint Surg Am 1996; 78:284.
48. Case of the week. Newborn infant with hepatomegaly. VCU Health System. http://www.ped
sradiology.com/Historyanswer.aspx?qid=144&fid=1 (Accessed on August 12, 2011).
https://www.uptodate.com/contents/14428/print 22/56
6/19/22, 10:55 PM 14428
49. Rasool MN, Govender S. The skeletal manifestations of congenital syphilis. A review of 197
cases. J Bone Joint Surg Br 1989; 71:752.
50. Cremin BJ, Fisher RM. The lesions of congenital syphilis. Br J Radiol 1970; 43:333.
51. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted
diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
52. American Academy of Pediatrics. Syphilis. In: Red Book: 2021-2024 Report of the Committe
e on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), A
merican Academy of Pediatrics, Itasca, IL 2021. p.729.
53. Lascari AD, Diamond J, Nolan BE. Anemia as the only presenting manifestation of
congenital syphilis. Clin Pediatr (Phila) 1976; 15:90.
54. Bulova SI, Schwartz E, Harrer WV. Hydrops fetalis and congenital syphilis. Pediatrics 1972;
49:285.
55. Chakraborty R, Luck S. Syphilis is on the increase: the implications for child health. Arch Dis
Child 2008; 93:105.
56. PUTKONEN T. Does early treatment prevent dental changes in congenital syphilis? Acta
Derm Venereol 1963; 43:240.
57. Stamos JK, Rowley AH. Timely diagnosis of congenital infections. Pediatr Clin North Am
1994; 41:1017.
58. OKSALA A. Interstitial keratitis after adequate penicillin therapy; a case report. Br J Vener
Dis 1957; 33:113.
59. Fiumara NJ, Lessell S. Manifestations of late congenital syphilis. An analysis of 271 patients.
Arch Dermatol 1970; 102:78.
60. Dorfman DH, Glaser JH. Congenital syphilis presenting in infants after the newborn period.
N Engl J Med 1990; 323:1299.
61. Adams DA, Kerr AG, Smyth GD, Cinnamond MJ. Congenital syphilitic deafness--a further
review. J Laryngol Otol 1983; 97:399.
62. Hardy JB, Hardy PH, Oppenheimer EH, et al. Failure of penicillin in a newborn with
congenital syphilis. JAMA 1970; 212:1345.
63. Rawstron SA, Vetrano J, Tannis G, Bromberg K. Congenital syphilis: detection of Treponema
pallidum in stillborns. Clin Infect Dis 1997; 24:24.
64. Burstain JM, Grimprel E, Lukehart SA, et al. Sensitive detection of Treponema pallidum by
using the polymerase chain reaction. J Clin Microbiol 1991; 29:62.
65. Larsen SA. Syphilis. Clin Lab Med 1989; 9:545.
https://www.uptodate.com/contents/14428/print 23/56
6/19/22, 10:55 PM 14428
66. Rawstron SA, Bromberg K. Comparison of maternal and newborn serologic tests for
syphilis. Am J Dis Child 1991; 145:1383.
67. Stoll BJ, Lee FK, Larsen S, et al. Clinical and serologic evaluation of neonates for congenital
syphilis: a continuing diagnostic dilemma. J Infect Dis 1993; 167:1093.
68. Lefevre JC, Bertrand MA, Bauriaud R. Evaluation of the Captia enzyme immunoassays for
detection of immunoglobulins G and M to Treponema pallidum in syphilis. J Clin Microbiol
1990; 28:1704.
69. Woznicová V, Smajs D, Wechsler D, et al. Detection of Treponema pallidum subsp. pallidum
from skin lesions, serum, and cerebrospinal fluid in an infant with congenital syphilis after
clindamycin treatment of the mother during pregnancy. J Clin Microbiol 2007; 45:659.
74. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance Syste
m. http://www.cdc.gov/osels/ph_surveillance/nndss/phs/infdis.htm (Accessed on August 1
2, 2011).
Topic 14428 Version 34.0
https://www.uptodate.com/contents/14428/print 24/56
6/19/22, 10:55 PM 14428
GRAPHICS
United States Centers for Disease Control and Prevention surveillance case
definition for congenital syphilis
Case classification
Probable
An infant whose mother had untreated or inadequately treated* syphilis at delivery, regardless of
signs in the infant, or
An infant or child who has a reactive non-treponemal test for syphilis (VDRL, RPR, or equivalent
methods) and any of the following:
Evidence of congenital syphilis on physical examination¶
Evidence of congenital syphilis on radiographs of long bones
Reactive CSF VDRL
Elevated CSF WBC count or CSF protein (in a nontraumatic LP and without any other cause)Δ
Confirmed
Any case that is laboratory confirmed according to the laboratory criteria above
PCR: polymerase chain reaction; VDRL: venereal disease research laboratory; RPR: rapid plasma
reagin; CSF: cerebrospinal fluid; WBC: white blood cell; LP: lumbar puncture; CDC: United States
Centers for Disease Control and Prevention.
¶ Physical examination findings of congenital syphilis in an infant or child <2 years old may include
hepatosplenomegaly, rash, condyloma lata, snuffles, jaundice (nonviral hepatitis), pseudoparalysis,
pallor (anemia), or edema (nephrotic syndrome and/or malnutrition). Findings in older children may
include interstitial keratitis, hearing loss, anterior bowing of shins, frontal bossing, mulberry molars,
Hutchinson teeth, saddle nose, rhagades, or Clutton joints. Refer to UpToDate topic on congenital
syphilis for additional details.
https://www.uptodate.com/contents/14428/print 25/56
6/19/22, 10:55 PM 14428
During the first 30 days after birth – CSF WBC count >15 WBC/mm3 or CSF protein >120
mg/dL is abnormal
For infants and children >30 days old – CSF WBC count >5 WBC/mm3 or CSF protein >40
mg/dL is abnormal
Adapted from: Centers for Disease Control and Prevention. Syphilis (Treponema pallidum) 2018 Case Definition.
https://ndc.services.cdc.gov/case-definitions/syphilis-2018/ (Accessed on June 17, 2021).
https://www.uptodate.com/contents/14428/print 26/56
6/19/22, 10:55 PM 14428
Inadequate therapy
Treatment with a nonpenicillin antibiotic
Treatment less than four weeks before delivery (including treatment with penicillin)
Maternal non-treponemal antibody titers did not decline at least fourfold (two dilutions) after
treatment
Maternal non-treponemal antibody titers suggest reinfection or relapse (ie, fourfold increase)
* Non-treponemal test: Rapid plasma reagin (RPR) test or Venereal Disease Research Laboratory
(VDRL) test.
References:
1. Centers for Disease Control and Prevention. Syphilis (Treponema pallidum) 2018 Case Definition.
https://ndc.services.cdc.gov/case-definitions/syphilis-2018/ (Accessed on June 17, 2021).
2. American Academy of Pediatrics. Syphilis. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases,
32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021.
p.729.
3. Workowski KA, Bolan GA. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
https://www.uptodate.com/contents/14428/print 27/56
6/19/22, 10:55 PM 14428
Congenital syphilis: Reported cases among infants by year of birth and rates
of primary and secondary syphilis among women, United States, 2009 to
2018
Reproduced from: Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018: Syphilis.
Available at: https://www.cdc.gov/std/stats18/Syphilis.htm (Accessed on March 25, 2021).
https://www.uptodate.com/contents/14428/print 28/56
6/19/22, 10:55 PM 14428
Country or region
Condition
Russia China Guatemala Korea Africa
Hepatitis A
Hepatitis B
- Helminths <1 percent <1 percent <1 percent <1 percent 15 percent
Data from:
1. Abdulla RY, Rice MA, Donauer S, et al. Hepatitis A in internationally adopted children: Screening for acute and
previous infection. Pediatrics 2010; 126:e1039.
2. Stadler LP, Mezoff AG, Staat MA. Hepatitis B virus screening for internationally adopted children. Pediatrics 2008;
122:1223.
3. Trehan I, Meinzen-Derr JK, Jamison L, Staat MA. Tuberculosis screening in internationally adopted children: the need
for initial and repeat testing. Pediatrics 2008; 122:e7.
4. Staat MA, Rice M, Donauer S, et al. Intestinal parasite screening in internationally adopted children: Importance of
testing multiple stool specimens. Pediatrics 2011; 128:e613.
5. Staat MA, Rice M, Leach K, Rawlings A. Medical Conditions in Internationally Adopted Children from Africa [abstract].
Pediatric Academy Societies Annual Meeting: Boston Massachusetts, 2012.
https://www.uptodate.com/contents/14428/print 29/56
6/19/22, 10:55 PM 14428
Gestational/perinatal
Stillbirth
Prematurity
Systemic
Failure to thrive
Mucocutaneous
Syphilitic rhinitis ("snuffles") Can be an early feature, developing after the first week of
life; contains spirochetes and is infectious (use contact
precautions)
Maculopapular rash Usually appears one to two weeks after rhinitis. Oval
lesions, initially red or pink and then coppery brown; may
be associated with superficial desquamation or scaling,
particularly on the palms or soles; more common on the
buttocks, back, posterior thighs, and soles; contains
spirochetes and is infectious (use contact precautions).
Vesicular rash (pemphigus May be present at birth, most often develops in first four
syphiliticus) weeks; widely disseminated; vesicular fluid contains
spirochetes and is infectious (use contact precautions)
Condylomata lata Single or multiple, flat, wartlike, moist lesions around the
https://www.uptodate.com/contents/14428/print 30/56
6/19/22, 10:55 PM 14428
mouth, nares, and anus and other areas of the skin where
there is moisture or friction; lesions contain spirochetes
and are infectious (use contact precautions); frequently
present without other signs of infection
Hematologic
Leukopenia
Leukocytosis
Musculoskeletal
Pseudoparalysis of Parrot Lack of movement of an extremity because of pain
associated with bone lesion; affects upper extremities
more often than lower; usually unilateral; rarely present at
birth; poorly correlated with radiographic abnormalities
Neurologic
CSF abnormalities Reactive CSF VDRL; elevated CSF white blood cell count;
elevated CSF protein
Acute syphilitic leptomeningitis Onset during the first year of life, usually between 3 and 6
months; presentation similar to bacterial meningitis but
CSF findings more consistent with aseptic meningitis
(mononuclear predominance); responds to penicillin
therapy
Chronic meningovascular syphilis Onset toward the end of the first year; hydrocephalus;
cranial nerve palsies; intellectual/neurodevelopmental
https://www.uptodate.com/contents/14428/print 31/56
6/19/22, 10:55 PM 14428
Miscellaneous
Pneumonia/pneumonitis/respiratory Complete opacification of both lung fields on chest
distress radiograph
* All of these findings may occur in other congenital infections; none is specific for congenital
syphilis.
Data from:
1. Ingall D, Sanchez PJ, Baker CH. Syphilis. In: Infectious Diseases of the Fetus and Newborn infant, 6th edition,
Remington JS, Klein JO, Wilson CB, Baker CJ (Eds), Elsevier Saunders, Philadelphia 2006. p.545.
2. Dobson SR, Sanchez PJ. Syphilis. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 7th, Cherry JD,
Harrison GJ, Kaplan SL, et al. (Eds), Elsevier Saunders, Philadelphia 2014. p.1761.
3. Woods CR. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis 2005; 16:245.
4. Saloojee H, Velaphi S, Goga Y, et al. The prevention and management of congenital syphilis: an overview and
recommendations. Bull World Health Organ 2004; 82:424.
5. Chakraborty R, Luck S. Syphilis is on the increase: the implications for child health. Arch Dis Child 2008; 93:105.
6. Rawstron SA. Treponema pallidum (Syphilis). In: Principles and Practice of Pediatric Infectious Diseases, 3rd edition,
Long SS, Pickering LK, Prober CG (Eds), Churchill Livingstone Elsevier, Philadelphia 2008. p.930.
https://www.uptodate.com/contents/14428/print 32/56
6/19/22, 10:55 PM 14428
Reproduced from: the Public Health Image Library, Centers for Disease Control and
Prevention. Photo by Dr. Norman Cole.
https://www.uptodate.com/contents/14428/print 33/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Fleisher GR, Ludwig W, Baskin MN. Atlas of
Pediatric Emergency Medicine. Lippincott Williams & Wilkins, Philadelphia 2004.
Copyright © 2004 Lippincott Williams & Wilkins.
https://www.uptodate.com/contents/14428/print 34/56
6/19/22, 10:55 PM 14428
https://www.uptodate.com/contents/14428/print 35/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Daffner RH. Clinical Radiology: The Essentials, 3rd
Edition. Lippincott Williams & Wilkins, Philadelphia 2007. Copyright © 2007
Lippincott Williams & Wilkins.
https://www.uptodate.com/contents/14428/print 36/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Yochum TR, Rowe LJ. Yochum And Rowe's
Essentials of Skeletal Radiology, 3rd ed. Lippincott Williams & Wilkins, Philadelphia
2004. Copyright © 2004 Lippincott Williams & Wilkins.
https://www.uptodate.com/contents/14428/print 37/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Eisenberg RL. An Atlas of Differential Diagnosis, 4th ed.
Lippincott Williams & Wilkins, Philadelphia 2003. Copyright © 2003 Lippincott Williams &
Wilkins.
https://www.uptodate.com/contents/14428/print 38/56
6/19/22, 10:55 PM 14428
Facial features Frontal bossing, saddle nose, short maxilla, protuberant mandible
Central nervous Intellectual disability, arrested hydrocephalus, seizures, optic atrophy, juvenile
system general paresis
Skeletal Saber shins (anterior bowing of the tibia), Higoumenakis sign (enlargement of the
sternoclavicular portion of the clavicle), Clutton joints (painless arthritis), scaphoid
scapula
Data from:
1. Ingall D, Sanchez PJ, Baker CH. Syphilis. In: Infectious Diseases of the Fetus and Newborn infant, 6th edition,
Remington JS, Klein JO, Wilson CB, Baker CJ (Eds), Elsevier Saunders, Philadelphia 2006. p.545.
2. Dobson SR, Sanchez PJ. Syphilis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th, Cherry JD,
Harrison GJ, Kaplan SL, et al. (Eds), Elsevier Saunders, Philadelphia 2014. p.1761.
3. Woods CR. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis 2005; 16:245.
4. Chakraborty R, Luck S. Syphilis is on the increase: the implications for child health. Arch Dis Child 2008; 93:105.
https://www.uptodate.com/contents/14428/print 39/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Bickley LS, Szilagyi P. Bates' Guide to Physical
Examination and History Taking, 8th ed, Lippincott Williams & Wilkins, Philadelphia
2003. Copyright © 2003 Lippincott Williams & Wilkins.
https://www.uptodate.com/contents/14428/print 40/56
6/19/22, 10:55 PM 14428
This photograph shows a stromal haze in both eyes of this child due
to interstitial keratitis, a manifestation of late congenital syphilis.
Interstitial keratitis is an inflammation of the connective tissue
structure of the cornea. It usually is bilateral.
Reproduced from: the Public Health Image Library, Centers for Disease Control and
Prevention. Photo by Susan Lindsley.
https://www.uptodate.com/contents/14428/print 41/56
6/19/22, 10:55 PM 14428
Hutchinson teeth are smaller and more widely spaced than normal
and are notched on their biting surfaces. The sides of the teeth
taper toward the biting edges. The upper central incisors of the
permanent (not the deciduous) teeth are most often affected.
Reproduced with permission from: Robinson HBG, Miller AS. Colby, Kerr, and
Robinson's Color Atlas of Oral Pathology. JB Lippincott, Philadelphia 1990. Copyright
© 1990 Lippincott Williams & Wilkins.
https://www.uptodate.com/contents/14428/print 42/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Sweet RL, Gibbs RS. Atlas of Infectious Diseases of
the Female Genital Tract. Lippincott Williams & Wilkins, Philadelphia 2005. Copyright
© 2005 Lippincott Williams & Wilkins.
https://www.uptodate.com/contents/14428/print 43/56
6/19/22, 10:55 PM 14428
Reproduced from: the Public Health Image Library, Centers for Disease Control and
Prevention. Photo by Susan Lindsley.
https://www.uptodate.com/contents/14428/print 44/56
6/19/22, 10:55 PM 14428
Reproduced from: the Public Health Image Library, Centers for Disease Control and
Prevention. Photo by Susan Lindsley.
https://www.uptodate.com/contents/14428/print 45/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Sweet RL, Gibbs RS. Atlas of Infectious Diseases of
the Female Genital Tract. Lippincott Williams & Wilkins, Philadelphia 2005. Copyright
© 2005 Lippincott Williams & Wilkins.
https://www.uptodate.com/contents/14428/print 46/56
6/19/22, 10:55 PM 14428
Reproduced from: the Public Health Image Library, Centers for Disease Control and
Prevention. Photo by Susan Lindsley.
https://www.uptodate.com/contents/14428/print 47/56
6/19/22, 10:55 PM 14428
https://www.uptodate.com/contents/14428/print 48/56
6/19/22, 10:55 PM 14428
Reproduced with permission from: Rubin E, Farber JL. Pathology, 3rd ed. Lippincott
Williams & Wilkins, Philadelphia 1999. Copyright © 1999 Lippincott Williams &
Wilkins.
https://www.uptodate.com/contents/14428/print 49/56
6/19/22, 10:55 PM 14428
RPR: rapid plasma reagin; VDRL: Venereal Disease Research Laboratory; TP-PA: Treponema pallidum particle a
antibody absorption; TP-EIA: T. pallidum enzyme immunoassay; MHA-TP: microhemagglutination test for ant
* This algorithm does not apply if maternal samples are screened in reverse order (ie, treponemal test is pe
of interpretation of reverse sequence testing, please refer to the UpToDate topic on diagnosis of syphilis.
Δ Test for HIV antibody. Infants of HIV-infected mothers do not require different evaluation or treatment.
◊ A fourfold change in titer is the same as a change of 2 dilutions. For example, a titer of 1:64 is fourfold gre
fourfold lower than a titer of 1:16.
§ Women who maintain a VDRL titer 1:2 or less or an RPR 1:4 or less beyond 1 year after successful treatmen
https://www.uptodate.com/contents/14428/print 50/56
6/19/22, 10:55 PM 14428
¥ Complete blood cell and platelet count; CSF examination for cell count, protein, and quantitative VDRL; oth
radiographs, long-bone radiographs, eye examination, liver function tests, neuroimaging, and auditory brai
‡ Some experts would consider a single intramuscular injection of benzathine penicillin (treatment option 2)
† Treatment (option 1 or option 2, above) with many experts recommending treatment option 1. If a single d
infant must be fully evaluated, full evaluation must be normal, and follow-up must be certain. If any part of t
performed, or if the CSF analysis is rendered uninterpretable, then a 10-day course of penicillin is required.
From: American Academy of Pediatrics. Syphilis. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering
Village, IL 2012. Copyright © 2012 American Academy of Pediatrics. Used with permission. The contents of this figure remain unchang
Infectious Diseases, 31st ed.
https://www.uptodate.com/contents/14428/print 51/56
6/19/22, 10:55 PM 14428
Initial neonatal
Maternal treatment Subsequent
evaluation Treatment
neonatal
of neonate
Neonate Neonate evaluation
Timing Type
VDRL/RPR evaluation
https://www.uptodate.com/contents/14428/print 52/56
6/19/22, 10:55 PM 14428
If any portion
of the
evaluation is
abnormal, not
performed, or
not
interpretable:
10 days of
parenteral
penicillin◊
https://www.uptodate.com/contents/14428/print 53/56
6/19/22, 10:55 PM 14428
Neonate characteristics in bold text indicate proven or highly probable congenital syphilis disease in
the infant.
VDRL: Venereal Disease Research Laboratory serologic test for syphilis; RPR: rapid plasma reagin
serologic test for syphilis; CSF: cerebrospinal fluid; CBC: complete blood count; IM: intramuscular; IV:
intravenous.
* Mother with reactive nontreponemal (VDRL or RPR) and treponemal (microhemagglutination test
for T. pallidum [MHA-TP] or fluorescent treponemal antibody absorption [FTA-ABS]) serologic tests
for syphilis. All such infants require clinical and serologic follow-up (see text for details).
¶ Examination findings compatible with early congenital syphilis may include (but are not limited to)
hepatomegaly/hepatosplenomegaly; rash; condyloma lata; snuffles; jaundice; pseudoparalysis;
anemia; and edema.
Δ Additional tests may include: Long-bone radiographs, chest radiograph, liver function tests, cranial
ultrasonography, ophthalmologic examination, and auditory brainstem response.
◊ There are two alternate regimens: Aqueous penicillin G (50,000 units/kg IV every 12 hours [for
infants ≤7 days of age] and every 8 hours [>7 days of age] for a total of 10 days); or procaine
penicillin G 50,000 units/kg IM as a single daily dose for 10 days.
§ Adequate therapy encompasses treatment with penicillin more than four weeks before delivery;
appropriate dose for the stage of disease; documentation of treatment response (fourfold decline in
titer for early syphilis and titer remained stable or low [VDRL ≤1:2; RPR ≤1:4] for late syphilis); no
evidence of reinfection or relapse (fourfold increase in titer after treatment).
† Normal CSF is generally defined by nonreactive VDRL, CSF WBC <25 cells/microL, and CSF protein
<150 mg/dL for term infants and <170 mg/dL for preterm infants; however, some experts define
normal CSF WBC as <5 cells/microL and normal CSF protein as <40 mg/dL.
References:
1. Workowski KA, Bolan GA. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
https://www.uptodate.com/contents/14428/print 54/56
6/19/22, 10:55 PM 14428
2. American Academy of Pediatrics. Syphilis. In: Red Book: 2018 Report of the Committee on Infectious Diseases, 31st ed,
Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.773.
3. Dobson SR, Sanchez PJ. Syphilis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD,
Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2019. p.1268.
4. Kollmann TR, Dobson SD. Syphilis. In: Infectious Diseases of the Fetus and Newborn infant, 7th edition, Remington JS,
Klein JO, Wilson CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.524.
https://www.uptodate.com/contents/14428/print 55/56
6/19/22, 10:55 PM 14428
Contributor Disclosures
Simon R Dobson, MD, FRCP(C) No relevant financial relationship(s) with ineligible companies to
disclose. Sheldon L Kaplan, MD Grant/Research/Clinical Trial Support: MeMed Diagnostics [Bacterial and
viral infections];Merck [Staphylococcus aureus];Pfizer [Streptococcus pneumoniae]. Consultant/Advisory
Boards: MeMed Advisory Board [Diagnostics bacterial and viral infections]. Other Financial Interest:
Elsevier [Pediatric infectious diseases];Pfizer [PCV13]. All of the relevant financial relationships listed have
been mitigated. Leonard E Weisman, MD Equity Ownership/Stock Options: Vax-Immune [Ureaplasma
diagnosis, vaccines, antibodies, other medical diagnostics and pre-analytical devices]. Patent Holder:
Baylor College of Medicine [Ureaplasma diagnosis, vaccines, antibodies, process for preparing biological
samples]. All of the relevant financial relationships listed have been mitigated. Carrie Armsby, MD,
MPH No relevant financial relationship(s) with ineligible companies to disclose.
Contributor disclosures are reviewed for conflicts of interest by the editorial group. When found, these are
addressed by vetting through a multi-level review process, and through requirements for references to be
provided to support the content. Appropriately referenced content is required of all authors and must
conform to UpToDate standards of evidence.
https://www.uptodate.com/contents/14428/print 56/56